CareRx Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CareRx Corporation's yearly results (2022–2025), compared with Healthcare companies in Canada. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every C$100 of sales, C$3 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against C$6 tied up three years earlier. Less money tied up than 86% of Healthcare companies in Canada.
Where C$100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
3.8×Over the last 3 years its own operating cash covered its investment spending (capex) 3.8 times.
Higher than 79% of Healthcare companies in Canada.
Cash Locked Ratio
C$3For every C$100 of sales, C$3 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against C$6 tied up three years earlier.
Less money tied up than 86% of Healthcare companies in Canada.
Growth quality
Steadiness Ratio
1/3 · 3/3Sales grew in 1 of the last 3 years; profit grew in 3 of 3.
Steadier than 55% of Healthcare companies in Canada.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -3% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-3% / -8%In 3 years sales changed by -3% while total assets changed by -8%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
6.0×Debt due within a year is covered 6.0 times by its yearly operating cash.
Higher than 72% of Healthcare companies in Canada.
Cash Cushion Ratio
−30%Debt, after subtracting cash, equals 30% of its market value (net debt).
Lower than 78% of Healthcare companies in Canada.
Tangible Assets Ratio
59%Of every C$100 the company owns, C$59 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 72% of Healthcare companies in Canada.
Tangible Net Worth Ratio
10%Of every C$100 of net worth, C$10 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 75% of Healthcare companies in Canada.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
CareRx Corporation owes C$0.55 for every C$1 it owns. CareRx Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Compared with Healthcare companies in Canada · latest annual results Dec 2025.
P/E ratio
8.1Investors pay C$8.1 for every C$1 of CareRx Corporation's yearly profit, lower than 83% of Healthcare companies in Canada.
P/B ratio
1.93The share price is 1.93 times CareRx Corporation's book value per share, lower than 54% of Healthcare companies in Canada.
Market cap
C$212 MThe total market value of all of CareRx Corporation's shares at today's price (share price × number of shares), larger than 79% of Healthcare companies in Canada. PosiCap size class: Mini Cap.
Net worth (book value)
C$110 MWhat CareRx Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
C$1.73Net worth divided by the number of shares. The share price of C$3.34 is 1.9 times this, which is the P/B above.
Return on equity (ROE)
27.3%CareRx Corporation earned 27.3% on its shareholders' money over the last year, higher than 93% of Healthcare companies in Canada.
Owes vs Owns
0.55×CareRx Corporation owes C$0.55 for every C$1 it owns (moderate), higher than 61% of Healthcare companies in Canada.
Dividend yield
2.63%CareRx Corporation pays 2.63% of its share price as dividends a year.
Revenue growth
+1%Revenue rose 1% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Profit growth
Back to profitCareRx Corporation returned to profit in the year to Dec 2025, after a loss the year before.
Profit margin
7.1%CareRx Corporation keeps C$7 of every C$100 of revenue as net profit.
Cash quality
1.2×Cash from CareRx Corporation's business was 1.2× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
1.7×CareRx Corporation's operating profit covered its interest costs 1.7 times in the year to Dec 2025.
Cash vs debt
Net debtCareRx Corporation had C$64 M more debt than cash (net debt) at Dec 2025.
Questions
What is CareRx Corporation's P/E ratio?
Investors pay C$8.1 for every C$1 of CareRx Corporation's yearly profit, lower than 83% of Healthcare companies in Canada.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CareRx Corporation: C$212 M ÷ C$110 M (30 Jun 2026) = 1.9.
What is CareRx Corporation's return on equity?
CareRx Corporation earned 27.3% on its shareholders' money over the last year, higher than 93% of Healthcare companies in Canada.
How much does CareRx Corporation owe compared with what it owns?
CareRx Corporation owes C$0.55 for every C$1 it owns (moderate), higher than 61% of Healthcare companies in Canada.
Does CareRx Corporation pay a dividend?
Yes. CareRx Corporation pays 2.63% of its share price as dividends a year.
Is CareRx Corporation's revenue growing?
Revenue rose 1% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.